Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Asterias Biotherapeutics Inc (AST)

Asterias Biotherapeutics Inc (AST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Asterias Biotherapeutics Inc 6300 DUMBARTON CIRCLE FREMONT CA 94555 USA

www.asteriasbiotherapeutics.com P: 510-456-3800

Description:

Asterias Biotherapeutics, Inc. is a biotechnology company. It is focused on the field of regenerative medicine. The Company's technologies center on stem cells capable of becoming all of the cell types in the human body, a property called pluripotency. It develops therapies based on pluripotent stem cells to treat diseases or injuries in a variety of medical fields, with an initial focus on the therapeutic areas of neurology and oncology. Asterias Biotherapeutics, Inc. is based in Menlo Park, California.

Key Statistics

Overview:

Market Capitalization, $K 52,319
Shares Outstanding, K 55,659
Annual Sales, $ 4,040 K
Annual Net Income, $ -28,370 K
Last Quarter Sales, $ 120 K
Last Quarter Net Income, $ -4,450 K
60-Month Beta 2.85
% of Insider Shareholders 5.58%
% of Institutional Shareholders 16.41%
Float, K 52,553
% Float 94.42%

Growth:

1-Year Return -51.54%
3-Year Return -82.17%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 03/21/19
Earnings Per Share ttm -0.39
EPS Growth vs. Prev Qtr 20.00%
EPS Growth vs. Prev Year 46.67%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AST Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -71.45%
Return-on-Assets % -58.07%
Profit Margin % -702.23%
Debt/Equity N/A
Price/Sales 70.70
Price/Cash Flow N/A
Price/Book 2.11
Book Value/Share -0.44
Interest Coverage -59.36
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar